Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy

To predict the cost-effectiveness of lamotrigine by evaluating the costs and health outcomes in treated patients. Lamotrigine adjunctive therapy has been found to be associated with decreased seizure frequency and severity in patients who are refractory to treatment with the older antiepileptic drug...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurology 1998-10, Vol.51 (4), p.1026-1033
Hauptverfasser:	MARKOWITZ, M. A, MAUSKOPF, J. A, HALPERN, M. T
Format:	Artikel
Sprache:	eng
Schlagworte:	Ambulatory Care Facilities - economics Anticonvulsants - administration & dosage Anticonvulsants - economics Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Cost of Illness Cost-Benefit Analysis Drug Costs Drug Resistance Epilepsy - drug therapy Epilepsy - economics Epilepsy - surgery Health Care Costs - statistics & numerical data Hospitalization - economics Hospitalization - statistics & numerical data Humans Lamotrigine Medical sciences Neuropharmacology Outcome Assessment (Health Care) - economics Pharmacology. Drug treatments Triazines - administration & dosage Triazines - economics United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!